According to GlaxoSmithKline spokeswoman Gwenan White, the company advised pulling the batch after reports of higher than normal occurrences of a side effect called anaphylaxis, which can include swollen tongues, throats and respiratory distress.
"We have advised health care professionals not to use that batch while health authorities and GlaxoSmithKline investigate," said White.
The batch of 172,000 doses had been distributed throughout Canada, but it is unclear how many doses from that batch had been given out before Glaxo advised that it be pulled. According to White, the company has distributed a total of 7.5 million doses of swine flu vaccine in Canada. More...
Don't miss:
"We have advised health care professionals not to use that batch while health authorities and GlaxoSmithKline investigate," said White.
The batch of 172,000 doses had been distributed throughout Canada, but it is unclear how many doses from that batch had been given out before Glaxo advised that it be pulled. According to White, the company has distributed a total of 7.5 million doses of swine flu vaccine in Canada. More...
Don't miss:
Cases of tamiflu resistant swine flu continue to rise in the UK
ReplyDeleteSwine Flu Information & Advice
Sean Rushforth